​Reuters was two-and-a-half minutes ahead of rivals on Eli Lilly’s unscheduled trading update, which showed fourth-quarter sales of its weight-loss
The post Lilly shares on track for worst day since 2021 after downbeat Zepbound sales forecast  appeared first on Reuters News Agency.   

Reuters was two-and-a-half minutes ahead of rivals on Eli Lilly’s unscheduled trading update, which showed fourth-quarter sales of its weight-loss drug Zepbound would miss Wall Street estimates. The drugmaker’s shares slumped 8% on the news. 

The post Lilly shares on track for worst day since 2021 after downbeat Zepbound sales forecast  appeared first on Reuters News Agency.

    Reuters News Agency Read More